Overview
Cosmin Tegla is an Oncologist in New York, New York. Dr. Tegla is rated as an Experienced provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Aspiration.
His clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
530 1st Ave, New York, NY 10016
111 Broadway, New York, NY 10006
240 E 38th St, New York, NY 10016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
Weill Medical College Of Cornell
Jeffrey Laurence is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Laurence is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Thrombocytopenia, Atypical Hemolytic Uremic Syndrome (aHUS), D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Tissue Biopsy.
Regional Cancer Care Associates LLC
Kelly Fitzpatrick is an Oncologist and a Hematologist in Neptune, New Jersey. Dr. Fitzpatrick is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). Her top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Congenital Antithrombin 3 Deficiency, and Bone Marrow Aspiration. Dr. Fitzpatrick is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Acquired AgranulocytosisDr. Tegla isExperienced. Learn about Acquired Agranulocytosis.
- Angioimmunoblastic T-cell LymphomaDr. Tegla isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- B-Cell LymphomaDr. Tegla isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Tegla isExperienced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid LeukemiaDr. Tegla isExperienced. Learn about Childhood Acute Myeloid Leukemia.